文献速递甲状腺疾病

甲状腺功能与贫血的关系:个体参与者数据的汇总分析

The Relation Between Thyroid Function and Anemia: A Pooled Analysis of Individual Participant Data.
PubMed 文献 · J Clin Endocrinol Metab · 2018-01-01

本研究基于甲状腺研究协作组16个队列的42,162名参与者,采用个体参与者数据荟萃分析,横断面分析显示甲状腺功能异常者贫血风险增加,纵向分析显示基线甲状腺功能减退与随访期间贫血风险增加相关。

要点

  • 横断面分析中,甲状腺功能异常者贫血风险均高于甲状腺功能正常者。
  • 纵向分析中,基线亚临床甲状腺功能减退者贫血风险增加(HR 1.18,95%CI 1.00-1.38)。
  • 尚需随机对照试验评估治疗甲状腺功能异常能否减少贫血。

核心结论

  • 甲状腺功能减退和甲状腺功能亢进均与贫血患病风险增加相关。
  • 基线甲状腺功能减退显示随访期间贫血风险增加的趋势。

研究设计与样本

  • 个体参与者数据荟萃分析,纳入甲状腺研究协作组的16个队列,共42,162名参与者。
  • 纵向分析纳入来自14个队列的25,466名参与者。

主要发现

  • 横断面分析中,与甲状腺功能正常者相比,贫血的合并OR:显性甲状腺功能减退1.84(95%CI 1.35-2.50),亚临床甲状腺功能减退1.21(1.02-1.43),亚临床甲状腺功能亢进1.27(1.03-1.57),显性甲状腺功能亢进1.69(1.00-2.87)。
  • 所有甲状腺功能异常组的血红蛋白水平均低于甲状腺功能正常组。
  • 纵向分析中,发生贫血的合并HR:显性甲状腺功能减退1.38(95%CI 0.86-2.20),亚临床甲状腺功能减退1.18(1.00-1.38),亚临床甲状腺功能亢进1.15(0.94-1.42),显性甲状腺功能亢进1.47(0.91-2.38)。
  • 各甲状腺激素状态组间血红蛋白的年平均变化无差异。

临床怎么用

  • 对甲状腺功能异常患者,尤其是甲状腺功能减退者,应关注贫血的筛查与评估。
  • 治疗甲状腺功能异常是否可减少贫血尚需随机对照试验验证。

局限性

  • 纵向分析中部分结果置信区间较宽,需谨慎解读。
  • 研究为观察性设计,无法确定因果关系。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

CONTEXT: Anemia and thyroid dysfunction often co-occur, and both increase with age. Human data on relationships between thyroid disease and anemia are scarce. OBJECTIVE: To investigate the cross-sectional and longitudinal associations between clinical thyroid status and anemia. DESIGN: Individual participant data meta-analysis. SETTING: Sixteen cohorts participating in the Thyroid Studies Collaboration (n = 42,162). MAIN OUTCOME MEASURES: Primary outcome measure was anemia (hemoglobin <130 g/L in men and <120 g/L in women). RESULTS: Cross-sectionally, participants with abnormal thyroid status had an increased risk of having anemia compared with euthyroid participants [overt hypothyroidism, pooled OR 1.84 (95% CI 1.35 to 2.50), subclinical hypothyroidism 1.21 (1.02 to 1.43), subclinical hyperthyroidism 1.27 (1.03 to 1.57), and overt hyperthyroidism 1.69 (1.00 to 2.87)]. Hemoglobin levels were lower in all groups compared with participants with euthyroidism. In the longitudinal analyses (n = 25,466 from 14 cohorts), the pooled hazard ratio for the risk of development of anemia was 1.38 (95% CI 0.86 to 2.20) for overt hypothyroidism, 1.18 (1.00 to 1.38) for subclinical hypothyroidism, 1.15 (0.94 to 1.42) for subclinical hyperthyroidism, and 1.47 (0.91 to 2.38) for overt hyperthyroidism. Sensitivity analyses excluding thyroid medication or high levels of C-reactive protein yielded similar results. No differences in mean annual change in hemoglobin levels were observed between the thyroid hormone status groups. CONCLUSION: Higher odds of having anemia were observed in participants with both hypothyroid function and hyperthyroid function. In addition, reduced thyroid function at baseline showed a trend of increased risk of developing anemia during follow-up. It remains to be assessed in a randomized controlled trial whether treatment is effective in reducing anemia.

来源:J Clin Endocrinol Metab,查看原文。版权归原作者所有。

引用

  1. Wopereis DM, Du Puy RS, van Heemst D, et al. The Relation Between Thyroid Function and Anemia: A Pooled Analysis of Individual Participant Data. J Clin Endocrinol Metab. 2018. PMID: 30113667. doi:10.1210/jc.2018-00481

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。